Hanbeta®Bevacizumab Injection Instructions for Use

Hanbeta® (bevacizumab) is a biosimilar to Avastin® (bevacizumab) developed by Fosun Pharma, and is indicated for the treatment of metastatic colorectal cancer, advanced, metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, hepatocellular carcinoma, etc.

File format
PDF
Published
30 October, 2023
Updated
30 October, 2023
MD5 checksum
469A5D8C3D7712B661658CB6AE161EF2
PDF
Hanbeta®Bevacizumab Injection Instructions for Use PDF
Download PDF

Also Manuals

ManualLib.com

ManualLib.com is a comprehensive platform that offers an extensive collection of instruction manuals for a diverse range of products from around the globe. Our mission is to provide users with easy access to these manuals at all times and from any location, enabling them to make the most out of their purchases and improve their user experience.